A better understanding of the molecular mechanisms by which ATF3 overexpression initiates mammary tumorigenesis in the transgenic mouse model may provide new biomarkers and/or therapeutic targets for a subset of human breast tumors. The gene discussed is ATF3; the disease is breast neoplasm.